Protection from pulmonary ischemia-reperfusion injury by adenosine A2A receptor activation
TLDR
Specific activation of A2AARs provides potent protection against lung IR injury via attenuation of inflammation, and occurs in the absence of circulating blood thereby indicating a protective role of A 2AAR activation on resident lung cells such as alveolar macrophages.Abstract:
Background: Lung ischemia-reperfusion (IR) injury leads to significant morbidity and mortality which remains a major obstacle after lung transplantation. However, the role of various subset(s) of lung cell populations in the pathogenesis of lung IR injury and the mechanisms of cellular protection remain to be elucidated. In the present study, we investigated the effects of adenosine A 2A receptor (A 2A AR) activation on resident lung cells after IR injury using an isolated, bufferperfused murine lung model. Methods: To assess the protective effects of A2AAR activation, three groups of C57BL/6J mice were studied: a sham group (perfused for 2 hr with no ischemia), an IR group (1 hr ischemia + 1 hr reperfusion) and an IR+ATL313 group where ATL313, a specific A 2A AR agonist, was included in the reperfusion buffer after ischemia. Lung injury parameters and pulmonary function studies were also performed after IR injury in A2AAR knockout mice, with or without ATL313 pretreatment. Lung function was assessed using a buffer-perfused isolated lung system. Lung injury was measured by assessing lung edema, vascular permeability, cytokine/chemokine activation and myeloperoxidase levels in the bronchoalveolar fluid. Results: After IR, lungs from C57BL/6J wild-type mice displayed significant dysfunction (increased airway resistance, pulmonary artery pressure and decreased pulmonary compliance) and significant injury (increased vascular permeability and edema). Lung injury and dysfunction after IR were significantly attenuated by ATL313 treatment. Significant induction of TNF-α, KC (CXCL1), MIP-2 (CXCL2) and RANTES (CCL5) occurred after IR which was also attenuated by ATL313 treatment. Lungs from A2AAR knockout mice also displayed significant dysfunction, injury and cytokine/ chemokine production after IR, but ATL313 had no effect in these mice. Conclusion: Specific activation of A 2A ARs provides potent protection against lung IR injury via attenuation of inflammation. This protection occurs in the absence of circulating blood thereby indicating a protective role of A2AAR activation on resident lung cells such as alveolar macrophages. Specific A 2A AR activation may be a promising therapeutic target for the prevention or treatment of pulmonary graft dysfunction in transplant patients.read more
Citations
More filters
Journal ArticleDOI
Targeting purinergic receptors to suppress the cytokine storm induced by SARS-CoV-2 infection in pulmonary tissue
Júlia Leão Batista Simões,Helena Fornari Basso,Greicy Cristine Kosvoski,Jullye Gavioli,Filomena Marafon,Charles Elias Assmann,Fabiano B. Carvalho,Margarete Dulce Bagatini +7 more
TL;DR: The etiological agent of coronavirus disease (COVID-19) is the new member of the Coronaviridae family, a severe acute respiratory syndrome (SARS-CoV-2) responsible for the pandemic that is plaguing the world.
Journal ArticleDOI
Anti-inflammatory, antioxidant, and antiparkinsonian effects of adenosine A2A receptor antagonists.
Małgorzata Zygmunt,Krystyna Gołembiowska,Anna Drabczyńska,Katarzyna Kieć-Kononowicz,Jacek Sapa +4 more
TL;DR: It is concluded that anti-inflammatory and antiparkinsonian effects of the examined compounds correlate with their influence on adenosine A2A receptors, the most probable antagonism to these subtype receptors.
Journal ArticleDOI
Inhibition of mitochondrial autophagy protects donor lungs for lung transplantation against ischaemia-reperfusion injury in rats via the mTOR pathway.
TL;DR: Inhibition of I‐R‐induced mitochondrial autophagy alleviated lung injury via the mTOR pathway, suggesting a potential therapeutic strategy for lung I/R injury.
Journal ArticleDOI
SPECT imaging of lung ischemia-reperfusion injury using [99mTc]cFLFLF for molecular targeting of formyl peptide receptor 1
Eric J. Charles,Mahendra D. Chordia,Yunge Zhao,Yi Zhang,J. Hunter Mehaffey,David K. Glover,Julien Dimastromatteo,W. Zachary Chancellor,Ashish Sharma,Irving L. Kron,Dongfeng Pan,X. Victor E. Laubach +11 more
TL;DR: Clinical application of 99mTc-cFLFLF SPECT enables noninvasive detection of lung IRI and permits monitoring of resolution of injury over time, correlating with resolution of IRI as shown by improved lung function and decreased neutrophil infiltration.
Book ChapterDOI
Animal Models of Airway Diseases
TL;DR: This chapter provides an in-depth description of each in vivo study, and a critical view of the therapeutic potentials for the treatment of airway diseases.
References
More filters
Journal ArticleDOI
Ischemia-reperfusion-induced lung injury.
TL;DR: Better understanding of the mechanisms of ischemia-reperfusion injury, improvements in the technique of lung preservation, and the development of a new preservation solution specifically for the lung have been associated with a reduction in the incidence of primary graft failure from approximately 30 to 15% or less.
Journal ArticleDOI
Molecular Approach to Adenosine Receptors: Receptor-Mediated Mechanisms of Tissue Protection
TL;DR: Novel adenosine receptor subtype-selective ligands have recently been developed that will help investigators to sort out how adenoine protects tissues from injury and to identify new therapeutic agents that hold promise for the treatment of inflammatory and ischemic diseases.
Journal ArticleDOI
Adenosine, an endogenous anti-inflammatory agent.
TL;DR: The observations reviewed here suggest that adenosine and agents that act throughadenosine are excellent candidates for development as anti-inflammatory agents.
Journal ArticleDOI
Pulmonary atelectasis: a pathogenic perioperative entity.
TL;DR: The authors discuss the effects and implications of atelectasis in the perioperative period and illustrate how preventive measures may impact outcome and the impact of atElectasis and its prevention in acute lung injury.
Journal ArticleDOI
Obliterative bronchiolitis after lung and heart-lung transplantation: An analysis of risk factors and management
Ko Bando,Irvin L. Paradis,Shari L. Similo,Hiroaki Konishi,Kanshi Komatsu,Thomas G. Zullo,Samuel A. Yousem,John M. Close,Adriana Zeevi,Rene J. Duquesnoy,Jan D. Manzetti,Robert J. Keenan,John M. Armitage,Robert L. Hardesty,Bartley P. Griffith +14 more
TL;DR: Recipients with obliterative bronchiolitis detected in the preclinical stage were significantly more likely to be in remission than recipients who had clinical disease at the time of diagnosis and results indicate that acute rejection is the most significant risk factor for development of obliteration and that obliteration responds to treatment with augmented immunosuppression when it is detected early by surveillance transbronchial biopsy.
Related Papers (5)
Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage.
Akio Ohta,Michail V. Sitkovsky +1 more